This contract expires in 64 days (Aug 9, 2026).
MCKESSON CORPORATION - PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 PERFORMANCE PERIOD #2 8-10-24 THROUGH 8-9-26 EXPIRES 8-8-2028
Key Details
Description
PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 PERFORMANCE PERIOD #2 8-10-24 THROUGH 8-9-26 EXPIRES 8-8-2028
Context & Analysis
On Dec 17, 2025, Department of Justice obligated $100,000 to MCKESSON CORPORATION for prime vendor pharmceutical contract intragency agreement 943 contract # 36w79720d001 performance period #2 8-10-24 through 8-9-26 expires 8-8-2028. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. The contract is scheduled through Aug 9, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024
MCKESSON CORPORATION
$29.2M
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
MCKESSON CORPORATION
$10.0M
PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV
MCKESSON CORPORATION
$5.3M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
Stay Updated
Get notified about new opportunities matching your interests.